Zobrazeno 1 - 10
of 116
pro vyhledávání: '"Reza Nejati"'
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
While normal B- and T-lymphocytes require antigenic ligands to become activated via their B- and T-cell receptors (BCR and TCR, respectively), B- and T-cell lymphomas show the broad spectrum of cell activation mechanisms regarding their dependence on
Externí odkaz:
https://doaj.org/article/e75826e08b2347288533847c71029e4d
Autor:
Yavuz Sahin, Jianming Pei, Don A. Baldwin, Nashwa Mansoor, Lori Koslosky, Peter Abdelmessieh, Y. Lynn Wang, Reza Nejati, Joseph. R. Testa
Publikováno v:
Leukemia Research Reports, Vol 21, Iss , Pp 100465- (2024)
Acute myeloid leukemia (AML) is a heterogeneous hematological malignancy associated with various combinations of gene mutations, epigenetic abnormalities, and chromosome rearrangement-related gene fusions. Despite the significant degree of heterogene
Externí odkaz:
https://doaj.org/article/f0c3cc23a9b1481eaa5a4ec667934ac3
Autor:
Tingwei Guo, Don Baldwin, Yinfei Tan, Yulan Gong, Min Huang, Nicholas Mackrides, Reza Nejati, Yue Lynn Wang, Mariusz Wasik
Publikováno v:
Genetics in Medicine Open, Vol 2, Iss , Pp 100968- (2024)
Externí odkaz:
https://doaj.org/article/e121e72aef524d3d99637a57023f71ea
Autor:
Reza NEJATI, Mohsen JABBARI
Publikováno v:
Issues in Language Studies, Vol 12, Iss 2 (2023)
Language aptitude tests, such as the LLAMA_ B3, developed by Meara and Rogers (2022), may play an important role in vocabulary learning research. Following Bokander & Bylund's (2019) advice, the construct validity of this test is examined here. Data
Externí odkaz:
https://doaj.org/article/312f300128ed4124ae7f65884731ada4
Autor:
Yavuz Sahin, Y. Lynn Wang, Jianming Pei, Nashwa Mansoor, Michael Styler, Joseph R. Testa, Reza Nejati
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 1, p 305 (2023)
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematologic malignancy with an aggressive clinical course and poor prognosis. The genetic abnormalities in BPDCN are heterogeneous; therefore, its molecular pathogenesis and the prognosti
Externí odkaz:
https://doaj.org/article/a79605f3e0f244698ce199c1312c6701
Publikováno v:
Case Reports in Oncology, Vol 15, Iss 1, Pp 78-85 (2022)
Liquid biopsy is a valuable tool in advanced and metastatic cancers for detection of genomic alterations in tumors that facilitate personalized targeted therapy approaches. Analyzing circulating tumor DNA (ctDNA) using next-generation sequencing (NGS
Externí odkaz:
https://doaj.org/article/7d04d590fc5849aeaa98c94ea1e64b32
Autor:
Reza Nejati, Ryan Neumann-Domer, Zemin Liu, Lori Koslosky, Erin Neumann-Domer, Jianming Pei, Y. Lynn Wang, Joseph R. Testa
Publikováno v:
Leukemia Research Reports, Vol 20, Iss , Pp 100387- (2023)
We describe genomic findings in an AML case with isochromosome 7p, i(7)(p10), in which SNP array analysis uncovered an additional 7.07-Mb 20q deletion not detected by karyotyping. Several AML cases with i(7)(p10) as an isolated cytogenetic finding ha
Externí odkaz:
https://doaj.org/article/983bc9414f3c41d99a042aecf066b7b8
Autor:
Pin Lu, Shengchun Wang, Carrie A. Franzen, Girish Venkataraman, Rebecca McClure, Lei Li, Wenjun Wu, Nifang Niu, Madina Sukhanova, Jianming Pei, Donald A. Baldwin, Reza Nejati, Mariusz A. Wasik, Nadia Khan, Yifan Tu, Juehua Gao, Yihua Chen, Shuo Ma, Richard A. Larson, Y. Lynn Wang
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 2, Pp 1-14 (2021)
Abstract Ibrutinib inhibits Bruton tyrosine kinase while venetoclax is a specific inhibitor of the anti-apoptotic protein BCL2. Both drugs are highly effective as monotherapy against chronic lymphocytic leukemia (CLL), and clinical trials using the c
Externí odkaz:
https://doaj.org/article/849baea9e9ce42e89fc77c87bc31fab7
Autor:
Reza Nejati, Hessam Aldin Sahrapour
Publikováno v:
Teaching English Language, Vol 14, Iss 2, Pp 345-372 (2020)
Teacher efficacy may relate to their effectiveness in terms of class management, instructional strategies, and student achievement. Some questionnaires have been used to capture teachers' efficacy. The most frequently used one is theOhio State Teache
Externí odkaz:
https://doaj.org/article/1e870b0ebe144d9b818e40dd49fb2016
Autor:
Dmitry Zhigarev, Asya Varshavsky, Alexander W. MacFarlane, Prathiba Jayaguru, Laura Barreyro, Marina Khoreva, Essel Dulaimi, Reza Nejati, Christina Drenberg, Kerry S. Campbell
Publikováno v:
Cancers, Vol 14, Iss 14, p 3352 (2022)
Acute myeloid leukemia (AML) is an aggressive malignancy that requires rapid treatment with chemotherapies to reduce tumor burden. However, these chemotherapies can compromise lymphocyte function, thereby hindering normal anti-tumor immune responses
Externí odkaz:
https://doaj.org/article/7b676a45f4a64cd99b171e740f7b66cd